U S PHYSICAL THERAPY INC /NV Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
U S PHYSICAL THERAPY INC /NV (USPH) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of $12.02 million for the 3-month period ending 2019-12-31, per its 10-K filed 2020-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2020-02-28
- U S PHYSICAL THERAPY INC /NV income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2019-12-31 was $12.02M, a 12.13% decline year-over-year.
- U S PHYSICAL THERAPY INC /NV income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2019-09-30 was $13.07M, a 10.02% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2019-06-30 was $19.80M, a 49.59% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2019-03-31 was $12.38M, a 23.09% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2015 was $31.69M, a 4.16% increase from fiscal 2014.
- U S PHYSICAL THERAPY INC /NV income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2014 was $30.42M, a 17.00% increase from fiscal 2013.
- U S PHYSICAL THERAPY INC /NV income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2013 was $26.00M, a 2.39% decline from fiscal 2012.
- U S PHYSICAL THERAPY INC /NV income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2012 was $26.64M, a 0.15% decline from fiscal 2011.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|---|
| 2019-12-31 | $12.02M 10-K · filed 2020-02-28 | $25.08M derived: sum of 2 quarters · filed 2020-02-28 | $44.88M derived: sum of 3 quarters · filed 2020-02-28 | $57.26M derived: sum of 4 quarters · filed 2020-02-28 | |
| 2019-09-30 | $13.07M 10-K · filed 2020-02-28 | $32.87M derived: sum of 2 quarters · filed 2020-02-28 | $45.24M derived: sum of 3 quarters · filed 2020-02-28 | $58.92M derived: sum of 4 quarters · filed 2020-02-28 | |
| 2019-06-30 | $19.80M 10-K · filed 2020-02-28 | $32.17M derived: sum of 2 quarters · filed 2020-02-28 | $45.85M derived: sum of 3 quarters · filed 2020-02-28 | $57.73M derived: sum of 4 quarters · filed 2020-02-28 | |
| 2019-03-31 | $12.38M 10-K · filed 2020-02-28 | $26.05M derived: sum of 2 quarters · filed 2020-02-28 | $37.93M derived: sum of 3 quarters · filed 2020-02-28 | $51.16M derived: sum of 4 quarters · filed 2020-02-28 | |
| 2018-12-31 | $13.67M 10-K · filed 2020-02-28 | $25.55M derived: sum of 2 quarters · filed 2020-02-28 | $38.79M derived: sum of 3 quarters · filed 2020-02-28 | $48.84M derived: sum of 4 quarters · filed 2020-02-28 | |
| 2018-09-30 | $11.88M 10-K · filed 2020-02-28 | $25.11M derived: sum of 2 quarters · filed 2020-02-28 | $35.17M derived: sum of 3 quarters · filed 2020-02-28 | $43.88M derived: sum of 4 quarters · filed 2020-02-28 | |
| 2018-06-30 | $13.24M 10-K · filed 2020-02-28 | $23.29M derived: sum of 2 quarters · filed 2020-02-28 | $32.00M derived: sum of 3 quarters · filed 2020-02-28 | $38.59M derived: sum of 4 quarters · filed 2020-02-28 | |
| 2018-03-31 | $10.05M 10-K · filed 2020-02-28 | $18.76M derived: sum of 2 quarters · filed 2020-02-28 | $25.35M derived: sum of 3 quarters · filed 2020-02-28 | $31.74M derived: sum of 4 quarters · filed 2020-02-28 | |
| 2017-12-31 | $8.71M 10-K · filed 2019-03-18 | $15.30M derived: sum of 2 quarters · filed 2019-03-18 | $21.69M derived: sum of 3 quarters · filed 2019-03-18 | $27.72M derived: sum of 4 quarters · filed 2019-03-18 | |
| 2017-09-30 | $6.59M 10-K · filed 2019-03-18 | $12.98M derived: sum of 2 quarters · filed 2019-03-18 | $19.02M derived: sum of 3 quarters · filed 2019-03-18 | $25.53M derived: sum of 4 quarters · filed 2019-03-18 | |
| 2017-06-30 | $6.39M 10-K · filed 2019-03-18 | $12.42M derived: sum of 2 quarters · filed 2019-03-18 | $18.93M derived: sum of 3 quarters · filed 2019-03-18 | $25.07M derived: sum of 4 quarters · filed 2019-03-18 | |
| 2017-03-31 | $6.03M 10-K · filed 2019-03-18 | $12.54M derived: sum of 2 quarters · filed 2019-03-18 | $18.68M derived: sum of 3 quarters · filed 2019-03-18 | $26.35M derived: sum of 4 quarters · filed 2019-03-18 | |
| 2016-12-31 | $6.51M 10-K · filed 2018-03-14 | $12.64M derived: sum of 2 quarters · filed 2018-03-14 | $20.32M derived: sum of 3 quarters · filed 2018-03-14 | $26.27M derived: sum of 4 quarters · filed 2018-03-14 | |
| 2016-09-30 | $6.13M 10-K · filed 2018-03-14 | $7.97M 10-Q · filed 2016-11-04 | $13.80M derived: sum of 2 quarters · filed 2018-03-14 | $25.71M 10-Q · filed 2016-11-04 | $26.02M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | $7.67M 10-K · filed 2018-03-14 | $10.06M 10-Q · filed 2016-08-05 | $17.74M 10-Q · filed 2016-08-05 | $19.89M derived: sum of 3 quarters · filed 2018-03-14 | $26.86M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | $5.95M 10-K · filed 2018-03-14 | $7.68M 10-Q · filed 2016-05-06 | $12.22M derived: sum of 2 quarters · filed 2018-03-14 | $19.19M derived: sum of 3 quarters · filed 2018-03-14 | $27.15M derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | $6.26M 10-K · filed 2017-06-07 | $8.36M 10-K · filed 2016-03-04 | $13.24M derived: sum of 2 quarters · filed 2017-06-07 | $21.20M derived: sum of 3 quarters · filed 2017-06-07 | $31.69M 10-K · filed 2016-03-04 |
| 2015-09-30 | $6.97M 10-K · filed 2017-06-07 | $8.06M 10-Q · filed 2015-11-05 | $14.93M derived: sum of 2 quarters · filed 2017-06-07 | $23.33M 10-Q · filed 2016-11-04 | $27.49M derived: sum of 4 quarters · filed 2017-06-07 |
| 2015-06-30 | $7.96M 10-K · filed 2017-06-07 | $9.12M 10-Q · filed 2015-08-06 | $15.27M 10-Q · filed 2016-08-05 | $20.51M derived: sum of 3 quarters · filed 2017-06-07 | $27.93M derived: sum of 4 quarters · filed 2017-06-07 |
| 2015-03-31 | $5.29M 10-K · filed 2017-06-07 | $6.15M 10-Q · filed 2015-05-07 | $12.56M derived: sum of 2 quarters · filed 2017-06-07 | $19.97M derived: sum of 3 quarters · filed 2017-06-07 | $29.39M derived: sum of 4 quarters · filed 2017-06-07 |
| 2014-12-31 | $7.26M 10-K · filed 2016-03-04 | $14.68M derived: sum of 2 quarters · filed 2016-03-04 | $24.10M derived: sum of 3 quarters · filed 2016-03-04 | $30.42M 10-K · filed 2016-03-04 | |
| 2014-09-30 | $7.42M 10-K · filed 2016-03-04 | $16.84M derived: sum of 2 quarters · filed 2016-03-04 | $23.16M 10-Q · filed 2015-11-05 | $28.96M derived: sum of 4 quarters · filed 2016-03-04 | |
| 2014-06-30 | $9.42M 10-K · filed 2016-03-04 | $15.74M 10-Q · filed 2015-08-06 | $21.54M derived: sum of 3 quarters · filed 2016-03-04 | $28.30M derived: sum of 4 quarters · filed 2016-03-04 | |
| 2014-03-31 | $6.32M 10-K · filed 2016-03-04 | $12.12M derived: sum of 2 quarters · filed 2016-03-04 | $18.88M derived: sum of 3 quarters · filed 2016-03-04 | $26.52M derived: sum of 4 quarters · filed 2016-03-04 | |
| 2013-12-31 | $5.80M 10-K · filed 2015-03-12 | $12.55M derived: sum of 2 quarters · filed 2015-03-12 | $20.19M derived: sum of 3 quarters · filed 2015-03-12 | $26.00M 10-K · filed 2016-03-04 | |
| 2013-09-30 | $6.76M 10-K · filed 2015-03-12 | $14.40M derived: sum of 2 quarters · filed 2015-03-12 | $20.21M 10-Q · filed 2014-11-07 | $26.24M derived: sum of 4 quarters · filed 2015-03-12 | |
| 2013-06-30 | $7.64M 10-K · filed 2015-03-12 | $13.45M 10-Q · filed 2014-08-07 | $19.48M derived: sum of 3 quarters · filed 2015-03-12 | $25.91M derived: sum of 4 quarters · filed 2015-03-12 | |
| 2013-03-31 | $5.81M 10-K · filed 2015-03-12 | $11.84M derived: sum of 2 quarters · filed 2015-03-12 | $18.26M derived: sum of 3 quarters · filed 2015-03-12 | $25.72M derived: sum of 4 quarters · filed 2015-03-12 | |
| 2012-12-31 | $6.03M 10-K · filed 2014-03-11 | $12.46M derived: sum of 2 quarters · filed 2014-03-11 | $19.91M derived: sum of 3 quarters · filed 2014-03-11 | $26.64M 10-K · filed 2015-03-12 | |
| 2012-09-30 | $6.42M 10-K · filed 2014-03-11 | $6.40M 10-Q · filed 2013-11-07 | $13.88M derived: sum of 2 quarters · filed 2014-03-11 | $20.61M 10-Q · filed 2013-11-07 | |
| 2012-06-30 | $7.45M 10-K · filed 2014-03-11 | $14.19M derived: sum of 2 quarters · filed 2014-03-11 | |||
| 2012-03-31 | $6.73M 10-K · filed 2014-03-11 | ||||
| 2011-12-31 | $26.68M 10-K · filed 2014-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |